Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Accounts Payable

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Accounts Payable of $21.28 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-27 was $821.00K.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-28 was $20.45M, a 18.99% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-27 was -$37.88M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-27 was $24.51M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for fiscal 2025 was $2.87M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for fiscal 2024 was -$14.27M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for fiscal 2023 was -$20.43M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts payable for fiscal 2022 was -$2.65M, a 105.91% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 6 month as first filedIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 9 month as first filedIncrease (Decrease) in Accounts Payable 12 month
2026-06-27$821.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$21.28M
10-Q · filed 2026-08-05
-$16.60M
derived: sum of 3 quarters · filed 2026-08-05
$7.90M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$20.45M
10-Q · filed 2026-05-07
-$17.42M
derived: sum of 2 quarters · filed 2026-05-07
$7.08M
derived: sum of 3 quarters · filed 2026-05-07
-$1.93M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27-$37.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$13.37M
derived: sum of 2 quarters · filed 2026-02-18
-$22.38M
derived: sum of 3 quarters · filed 2026-08-05
$2.87M
10-K · filed 2026-02-18
2025-09-27$24.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$15.50M
derived: sum of 2 quarters · filed 2026-08-05
$40.75M
10-Q · filed 2025-11-05
$33.57M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28-$9.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$16.24M
10-Q · filed 2026-08-05
$9.06M
derived: sum of 3 quarters · filed 2026-08-05
$8.41M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$25.25M
10-Q · filed 2026-05-07
$18.07M
derived: sum of 2 quarters · filed 2026-05-07
$17.42M
derived: sum of 3 quarters · filed 2026-05-07
$19.52M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$7.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$7.83M
derived: sum of 2 quarters · filed 2026-02-18
-$5.73M
derived: sum of 3 quarters · filed 2026-02-18
-$14.27M
10-K · filed 2026-02-18
2024-09-28-$659.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$1.45M
derived: sum of 2 quarters · filed 2025-11-05
-$7.09M
10-Q · filed 2025-11-05
-$991.00K
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$6.44M
10-Q · filed 2025-08-06
-$332.00K
derived: sum of 3 quarters · filed 2026-02-18
-$1.88M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30-$8.54M
10-Q · filed 2025-05-07
-$2.44M
derived: sum of 2 quarters · filed 2026-02-18
-$3.98M
derived: sum of 3 quarters · filed 2026-02-18
$12.35M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30$6.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$4.56M
derived: sum of 2 quarters · filed 2026-02-18
$20.89M
derived: sum of 3 quarters · filed 2026-02-18
-$20.43M
10-K · filed 2026-02-18
2023-09-30-$1.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$14.78M
derived: sum of 2 quarters · filed 2024-11-06
-$26.53M
10-Q · filed 2024-11-06
-$35.16M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$16.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$24.98M
10-Q · filed 2024-08-07
-$33.62M
derived: sum of 3 quarters · filed 2025-02-19
-$59.10M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01-$41.31M
10-Q · filed 2024-05-09
-$49.94M
derived: sum of 2 quarters · filed 2025-02-19
-$75.43M
derived: sum of 3 quarters · filed 2025-02-19
-$84.90M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$8.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
-$34.12M
derived: sum of 2 quarters · filed 2025-02-19
-$43.58M
derived: sum of 3 quarters · filed 2025-02-19
-$2.65M
10-K · filed 2025-02-19
2022-09-24-$25.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$34.95M
derived: sum of 2 quarters · filed 2023-11-08
$5.98M
10-Q · filed 2023-11-08
$39.45M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25-$9.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$31.47M
10-Q · filed 2023-08-09
$64.94M
derived: sum of 3 quarters · filed 2024-02-14
$89.75M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26$40.93M
10-Q · filed 2023-05-11
$74.40M
derived: sum of 2 quarters · filed 2024-02-14
$99.22M
derived: sum of 3 quarters · filed 2024-02-14
$76.21M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$33.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$58.28M
derived: sum of 2 quarters · filed 2024-02-14
$35.28M
derived: sum of 3 quarters · filed 2024-02-14
$44.90M
10-K · filed 2024-02-14
2021-09-25$24.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$1.81M
derived: sum of 2 quarters · filed 2022-11-02
$11.43M
10-Q · filed 2022-11-02
$24.51M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26-$23.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$13.38M
10-Q · filed 2022-08-03
-$308.00K
derived: sum of 3 quarters · filed 2023-02-22
$12.98M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27$9.62M
10-Q · filed 2022-05-04
$22.70M
derived: sum of 2 quarters · filed 2023-02-22
$35.99M
derived: sum of 3 quarters · filed 2023-02-22
$20.37M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$13.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$26.37M
derived: sum of 2 quarters · filed 2023-02-22
$10.75M
derived: sum of 3 quarters · filed 2023-02-22
$748.00K
10-K · filed 2023-02-22
2020-09-26$13.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
-$2.32M
derived: sum of 2 quarters · filed 2021-11-03
-$12.33M
10-Q · filed 2021-11-03
-$7.03M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27-$15.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
-$25.62M
10-Q · filed 2021-08-04
-$20.32M
derived: sum of 3 quarters · filed 2022-02-16
-$14.04M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28-$10.00M
10-Q · filed 2021-05-04
-$4.71M
derived: sum of 2 quarters · filed 2022-02-16
$1.58M
derived: sum of 3 quarters · filed 2022-02-16
$9.53M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$5.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$11.58M
derived: sum of 2 quarters · filed 2022-02-16
$19.53M
derived: sum of 3 quarters · filed 2022-02-16
$29.77M
10-K · filed 2022-02-16
2019-09-28$6.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$14.24M
derived: sum of 2 quarters · filed 2020-10-29
$24.48M
10-Q · filed 2020-10-29
$17.07M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$7.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$18.20M
10-Q · filed 2020-08-05
$10.79M
derived: sum of 3 quarters · filed 2021-02-17
$18.07M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$10.24M
10-Q · filed 2020-05-07
$2.83M
derived: sum of 2 quarters · filed 2021-02-17
$10.12M
derived: sum of 3 quarters · filed 2021-02-17
-$1.41M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29-$7.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
-$124.00K
derived: sum of 2 quarters · filed 2021-02-17
-$11.66M
derived: sum of 3 quarters · filed 2021-02-17
-$12.73M
10-K · filed 2021-02-17
2018-09-29$7.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$4.25M
derived: sum of 2 quarters · filed 2019-11-06
-$5.32M
10-Q · filed 2019-11-06
$872.00K
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30-$11.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$12.61M
10-Q · filed 2019-07-31
-$6.41M
derived: sum of 3 quarters · filed 2020-02-11
-$5.75M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31-$1.08M
10-Q · filed 2019-05-07
$5.12M
derived: sum of 2 quarters · filed 2020-02-11
$5.79M
derived: sum of 3 quarters · filed 2020-02-11
$5.22M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$6.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$6.86M
derived: sum of 2 quarters · filed 2020-02-11
$6.29M
derived: sum of 3 quarters · filed 2020-02-11
$34.00K
10-K · filed 2020-02-11
2017-09-30$668.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$98.00K
derived: sum of 2 quarters · filed 2018-11-07
-$6.16M
10-Q · filed 2018-11-07
-$1.27M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01-$570.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$6.83M
10-Q · filed 2018-08-08
-$1.94M
derived: sum of 3 quarters · filed 2019-02-13
-$4.47M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01-$6.26M
10-Q · filed 2018-05-10
-$1.37M
derived: sum of 2 quarters · filed 2019-02-13
-$3.90M
derived: sum of 3 quarters · filed 2019-02-13
$6.47M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$4.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$2.35M
derived: sum of 2 quarters · filed 2019-02-13
$12.72M
derived: sum of 3 quarters · filed 2019-02-13
$22.08M
10-K · filed 2019-02-13
2016-09-24-$2.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$7.83M
derived: sum of 2 quarters · filed 2017-11-09
$17.18M
10-Q · filed 2017-11-09
$19.25M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$10.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$19.72M
10-Q · filed 2017-08-09
$21.79M
derived: sum of 3 quarters · filed 2018-02-13
$19.14M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$9.35M
10-Q · filed 2017-05-10
$11.42M
derived: sum of 2 quarters · filed 2018-02-13
$8.77M
derived: sum of 3 quarters · filed 2018-02-13
$7.49M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
-$578.00K
derived: sum of 2 quarters · filed 2018-02-13
-$1.86M
derived: sum of 3 quarters · filed 2018-02-13
$1.17M
10-K · filed 2018-02-13
2015-09-26-$2.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
-$3.93M
derived: sum of 2 quarters · filed 2016-11-02
-$894.00K
10-Q · filed 2016-11-02
$5.48M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27-$1.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$1.75M
10-Q · filed 2016-08-03
$8.13M
derived: sum of 3 quarters · filed 2017-02-14
$1.95M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28$3.04M
10-Q · filed 2016-05-04
$9.42M
derived: sum of 2 quarters · filed 2017-02-14
$3.23M
derived: sum of 3 quarters · filed 2017-02-14
$1.33M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27$6.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$195.00K
derived: sum of 2 quarters · filed 2017-02-14
-$1.71M
derived: sum of 3 quarters · filed 2017-02-14
$4.60M
10-K · filed 2017-02-14
2014-09-27-$6.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
-$8.09M
derived: sum of 2 quarters · filed 2015-11-04
-$1.78M
10-Q · filed 2015-11-04
-$1.17M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28-$1.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$4.40M
10-Q · filed 2015-07-30
$5.01M
derived: sum of 3 quarters · filed 2016-02-12
-$3.82M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$6.31M
10-Q · filed 2015-04-30
$6.92M
derived: sum of 2 quarters · filed 2016-02-12
-$1.91M
derived: sum of 3 quarters · filed 2016-02-12
$4.27M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$608.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$8.22M
derived: sum of 2 quarters · filed 2016-02-12
-$2.04M
derived: sum of 3 quarters · filed 2016-02-12
-$7.08M
10-K · filed 2016-02-12
2013-09-28-$8.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
-$2.65M
derived: sum of 2 quarters · filed 2014-10-30
-$7.69M
10-Q · filed 2014-10-30
-$4.20M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$6.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$1.14M
10-Q · filed 2014-08-07
$4.63M
derived: sum of 3 quarters · filed 2015-02-17
-$2.73M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30-$5.04M
10-Q · filed 2014-04-30
-$1.55M
derived: sum of 2 quarters · filed 2015-02-17
-$8.91M
derived: sum of 3 quarters · filed 2015-02-17
-$6.11M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29$3.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$3.87M
derived: sum of 2 quarters · filed 2015-02-17
-$1.07M
derived: sum of 3 quarters · filed 2015-02-17
-$3.26M
10-K · filed 2015-02-17
2012-09-29-$7.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
-$4.56M
derived: sum of 2 quarters · filed 2013-10-30
-$6.74M
10-Q · filed 2013-10-30
-$4.99M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$2.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$617.00K
10-Q · filed 2013-07-31
$2.37M
derived: sum of 3 quarters · filed 2014-02-25
$3.22M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$2.19M
10-Q · filed 2013-05-08
-$438.00K
derived: sum of 2 quarters · filed 2014-02-25
$418.00K
derived: sum of 3 quarters · filed 2014-02-25
-$2.15M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$2.60M
derived: sum of 2 quarters · filed 2014-02-25
$38.00K
derived: sum of 3 quarters · filed 2014-02-25
$2.21M
10-K · filed 2014-02-25
2011-09-24$856.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
-$1.71M
derived: sum of 2 quarters · filed 2012-11-01
$459.00K
10-Q · filed 2012-11-01
-$2.80M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25-$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$397.00K
10-Q · filed 2012-08-07
-$3.65M
derived: sum of 3 quarters · filed 2013-02-27
-$721.00K
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26$2.17M
10-Q · filed 2012-05-04
-$1.09M
derived: sum of 2 quarters · filed 2013-02-27
$1.85M
derived: sum of 3 quarters · filed 2013-02-27
-$2.45M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25-$3.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$324.00K
derived: sum of 2 quarters · filed 2013-02-27
-$4.62M
derived: sum of 3 quarters · filed 2013-02-27
$71.00K
10-K · filed 2013-02-27
2010-09-25$2.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
-$1.37M
derived: sum of 2 quarters · filed 2011-11-02
$3.33M
10-Q · filed 2011-11-02
$3.35M
10-Q · filed 2010-11-04
-$1.86M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26-$4.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
$395.00K
10-Q · filed 2011-08-03
$410.00K
10-Q · filed 2010-08-03
-$4.79M
derived: sum of 3 quarters · filed 2012-02-27
-$5.80M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27$4.70M
10-Q · filed 2011-05-04
-$492.00K
derived: sum of 2 quarters · filed 2012-02-27
-$1.50M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-26-$5.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
-$6.19M
derived: sum of 2 quarters · filed 2012-02-27
-$11.35M
10-K · filed 2012-02-27
2009-09-26-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04
-$6.16M
10-Q · filed 2010-11-04
2009-06-27-$5.16M
10-Q · filed 2010-08-03
2008-12-27$8.32M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71